Prior studies showed that immunotherapy and corticosteroid treatments could reduce the circulating MIF levels and attenuate inflammatory responses via regulating the Th1/Th2 inflammation balance in nasal polyps and rheumatoid arthritis (Ekinci, 2018; Bilsborrow et al., 2019). The gene discussed is MIF; the disease is rheumatoid arthritis.